Oral Sulopenem Versus Amoxicillin/Clavulanate for Uncomplicated Urinary Tract Infection in Adult Women
Phase 3
Completed
- Conditions
- CystitisUrinary Tract Infections
- Interventions
- Drug: Amoxicillin/clavulanate
- First Posted Date
- 2022-10-18
- Last Posted Date
- 2024-11-20
- Lead Sponsor
- Iterum Therapeutics, International Limited
- Target Recruit Count
- 2229
- Registration Number
- NCT05584657
- Locations
- 🇺🇸
Medical Facility3, Sugar Land, Texas, United States
🇺🇸Medical Facility6, Miami, Florida, United States
🇺🇸Medical Facility7, Miami, Florida, United States
Azithromycin Plus Hydroxychloroquine for COVID-19 Infection
Phase 3
Withdrawn
- Conditions
- Respiratory Tract Infection Viral
- Interventions
- First Posted Date
- 2021-08-30
- Last Posted Date
- 2021-10-28
- Lead Sponsor
- Iterum Therapeutics, International Limited
- Registration Number
- NCT05026801
- Locations
- 🇺🇸
Waterbury Hospial, Waterbury, Connecticut, United States
Safety, Tolerability, and Pharmacokinetics of Sulopenem in Adolescents
Phase 1
Withdrawn
- Conditions
- Urinary Tract InfectionsPyelonephritis AcuteIntraabdominal Infections
- Interventions
- First Posted Date
- 2021-01-08
- Last Posted Date
- 2022-06-13
- Lead Sponsor
- Iterum Therapeutics, International Limited
- Registration Number
- NCT04700787
- Locations
- 🇺🇸
Medical Facility, Saint Louis, Missouri, United States
Expanded Access Use of Sulopenem Etzadroxil/Probenecid for Complicated Urinary Tract Infection
- Conditions
- Complicated Urinary Tract InfectionAcute Pyelonephritis
- First Posted Date
- 2020-12-24
- Last Posted Date
- 2024-08-14
- Lead Sponsor
- Iterum Therapeutics, International Limited
- Registration Number
- NCT04682834
Efficacy of Ciprofloxacin for the Treatment of Uncomplicated Urinary Tract Infection (uUTI)
Phase 4
Completed
- Conditions
- Antibiotic Resistant InfectionUTI - Lower Urinary Tract Infection
- Interventions
- First Posted Date
- 2017-12-08
- Last Posted Date
- 2019-09-06
- Lead Sponsor
- Iterum Therapeutics, International Limited
- Target Recruit Count
- 250
- Registration Number
- NCT03366207
- Locations
- 🇺🇸
Restore Clinical Research, Cary, North Carolina, United States
Sulopenem Followed by Sulopenem-etzadroxil/Probenecid vs Ertapenem Followed by Cipro for Complicated UTI in Adults
Phase 3
Completed
- Conditions
- Complicated Urinary Tract Infections
- Interventions
- Drug: Sulopenem-Etzadroxil/ProbenecidDrug: Amoxicillin-clavulanate
- First Posted Date
- 2017-11-30
- Last Posted Date
- 2020-12-29
- Lead Sponsor
- Iterum Therapeutics, International Limited
- Target Recruit Count
- 1395
- Registration Number
- NCT03357614
- Locations
- 🇱🇻
Medical Facility, Valmiera, Latvia
Sulopenem Versus Ertapenem for Complicated Intra-abdominal Infection (cIAI)
Phase 3
Completed
- Conditions
- Intra Abdominal Infections
- Interventions
- Drug: Sulopenem-Etzadroxil/ProbenecidDrug: Amoxicillin-Clavulanate
- First Posted Date
- 2017-11-30
- Last Posted Date
- 2020-12-01
- Lead Sponsor
- Iterum Therapeutics, International Limited
- Target Recruit Count
- 674
- Registration Number
- NCT03358576
- Locations
- 🇵🇱
Medical Facility, Bielsk Podlaski, Poland
Oral Sulopenem-etzadroxil/Probenecid Versus Ciprofloxacin for Uncomplicated Urinary Tract Infection in Adult Women
Phase 3
Completed
- Conditions
- Uncomplicated Urinary Tract Infections
- Interventions
- Drug: Sulopenem-Etzadroxil/Probenecid
- First Posted Date
- 2017-11-28
- Last Posted Date
- 2021-01-12
- Lead Sponsor
- Iterum Therapeutics, International Limited
- Target Recruit Count
- 1671
- Registration Number
- NCT03354598
- Locations
- 🇺🇸
Medical Facility, South Jordan, Utah, United States
© Copyright 2025. All Rights Reserved by MedPath